5,5- dichloro- N- (1- cyanocyclopropyl)- 2- (4- (4- (methylsulfonyl)phenyl)- 1- (2,2,2- trifluoroethyl)- 1H- pyraazol- 3- yl)cyclohexanecarboxamide
a cathepsin K inhibitor; structure in first source
Also Known As:
MK 1256; MK-1256; MK1256
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results